Townsend Adam J.
SEC insider (Form 3/4/5 filer). CIK 0001773588. Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 29, 2025. Located in WALTHAM, MA.
Companies Townsend Adam J. has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief Commercial Officer
Townsend Adam J.
CIK: 0001773588
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APLS
Apellis Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 29, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect695 shares at avg. $29.52$21K - Jan 22, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect3.3K shares at avg. $30.43$101K - Jan 17, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect2.2K shares at avg. $29.96$66K - Jan 13, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect2.7K shares at avg. $28.70$77K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 695 | $29.52 | $20,519 | Direct |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 3,323 | $30.43 | $101,104 | Direct |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 2,201 | $29.96 | $65,938 | Direct |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 2,685 | $28.70 | $77,065 | Direct |
1-4 of 4 transactions